The challenges within Epilepsy Trials in Europe

On March 14, we presented, in collaboration with ECET, the webinar: The challenges within Epilepsy Trials in Europe During this webinar, guest speakers Prof. Jacqueline French, Prof. Alexis Arzimanoglou and Prof. Eugen Trinka discussed: - E...

A brand-new look!

We are excited to announce that Julius Clinical has a brand-new look and website as part of the ongoing evolution of our company’s brand. Why? Ever since its foundation in 2008, Julius Clinical has been based on a unique triangle of scientif...

By: Michelle Heuvelmans

NAFLD: patient identification strategies

In this webinar, Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely im...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.

The Alzheimer’s disease drug development landscape

Hosted by: Julius Clinical. Speakers: Pieter van Bokhoven | CSO| IAO Amsterdam Neuroscience AUMC Jort Vijverberg | Neurologist | Amsterdam Neuroscience AUMC Topics that are discussed during this webinar: All major trends in Alzh...

Speakers: Dr. Jort Vijverberg

Public health and policy responses to NAFLD/NASH

Topics that has been discussed: The Impact of NAFLD/NASH What is being done to tackle NAFLD/NASH globally and nationally What still needs to be done in the fight against NAFLD/NASH How can you/your country advance the battle against ...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.

Genetic architecture of NAFLD: where do we stand?

Genome-wide association studies have uncovered robust and reproducible associations between several genetic variations and the natural history of NAFLD. During this webinar, Professor Eric Trépo reviewed these findings that have provided compelli...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.
  • Webinars
  • Infectious Diseases & Vaccines, Vaccines

COVID-19 lessons from pandemic to endemic

We presented the webinar COVID-19 lessons from pandemic to endemic. During this webinar Prof. Jerome H. Kim, Director General of the International Vaccine Institute (IVI), discussed: - Pandemic preparedness – lessons learned - Clinical Devel...

Speakers: Leyla Kragten-Tabatabaie


"*" indicates required fields


Request for proposal

"*" indicates required fields

This field is for validation purposes and should be left unchanged.


Twitter Facebook LinkedIn